# Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)

> Financial Services · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/DMAA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ 3.70M | $ -335.9K | $ 950.0K | $ 137.77M |
| 2025 | $ 0 | $ 6.08M | $ -552.1K | $ 0 | $ 232.64M |
| 2024 | $ 0 | $ -152.7K | $ -60.4K | $ 662 | $ -244 |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.07 |
| Current Ratio | 0.02 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.20 |

## Other views

- [Metrics](https://sponda.capital/en/DMAA.md)
- [Charts](https://sponda.capital/en/DMAA/charts.md)
- [Compare](https://sponda.capital/en/DMAA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.